The new fluoride? FDA greenlights rapamycin oral health trial [Longevity.Technology]

In the News

Dec 8

Written By Teddy Otero

Longevity.Technology wrote about Optispan’s collaboration with the RAPID trial to assess the efficacy of rapamycin in treating periodontal disease.

Teddy Otero

Optimizing healthspan, empowering longevity clinics and exploring biological age. [Longevity.Technology]

Optispan CEO Matt Kaeberlein Named "Healthcare Innovator of the Year" by Puget Sound Business Journal